billHR10210Event Tuesday, September 1, 2026Analyzed

To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to regulate the use of artificial intelligence in the review of claims by group health plans and health insurance issuers offering group or individual health insurance coverage.

Bearish

Summary

HR10210, introduced September 1, 2026, would regulate the use of artificial intelligence in health insurance claims review, requiring transparency, human oversight, and non-discrimination standards. The bill is in early stage (referred to three committees) with bipartisan cosponsorship but low momentum. If enacted, it would increase compliance costs for health insurers ($UNH, $CI, $HUM, $ANTM, $MOH, $CVS) and reduce their ability to use AI for automated claim denials, potentially raising medical cost ratios. Near-term market impact is low given the legislative timeline.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR10210 targets AI use in health claims review, imposing compliance costs on insurers.
  • 2.Bill is early stage with low momentum; near-term market impact minimal.
  • 3.Health insurers ($UNH, $CI, $HUM, $ANTM, $MOH, $CVS) face potential operational headwinds if enacted.
  • 4.No funding or direct revenue impact; regulatory burden is the primary mechanism.

Market Implications

The bill introduces regulatory risk for health insurers that use AI for claims review. UnitedHealth Group, Cigna ($CI), Humana ($HUM), Elevance Health, Molina Healthcare ($MOH), and CVS Health ($CVS) are directly exposed. No real market data is available for current prices, but structurally, these stocks could face modest headwinds if the bill gains traction. The impact is limited by the early legislative stage and lack of funding. Investors should view this as a low-probability, moderate-impact regulatory risk.

Full Analysis

  1. What happened: On September 1, 2026, Rep. Greg Landsman (D-OH-1) introduced HR10210, a bill to amend three federal laws (Public Health Service Act, ERISA, and Internal Revenue Code) to regulate AI use in health claims review. The bill was referred to the Energy and Commerce, Ways and Means, and Education and Workforce committees. It has three original cosponsors (two Republicans, one Democrat), indicating bipartisan interest but limited early support. The bill is at the earliest legislative stage.

  2. The money trail: The bill does not authorize or appropriate any funding. It imposes regulatory requirements on group health plans and insurers. The primary economic effect is increased compliance costs for insurers that use AI in claims processing. No federal funds are involved; the cost falls on private sector entities. The Congressional Budget Office would score this as a private-sector mandate, potentially increasing premiums if costs are passed through.

  3. Convergence: No convergence with the provided presidential executive order (bulk-power system emergency) — that action addresses energy infrastructure, unrelated to healthcare AI regulation. No other related signals or procurements were provided. The bill stands alone as a targeted regulatory proposal.

  4. Structural winners and losers: The clear losers are health insurers that heavily use AI for claims review, including UnitedHealth Group, Cigna ($CI), Humana ($HUM), Elevance Health, Molina Healthcare ($MOH), and Aetna (CVS Health, $CVS). These companies face compliance costs and reduced automation efficiency. Technology vendors providing AI claims solutions (e.g., $CGNX, $IBM) may see reduced demand or increased compliance burdens, but the bill's primary target is insurers, not vendors. No clear winners emerge at this stage.

  5. Timeline: The bill is in early stage. Next steps: committee hearings and markups in any of the three referred committees. Given the 119th Congress runs through January 2027, the bill has ~16 months to advance. With a junior sponsor and limited cosponsors, passage probability is low in the current Congress. Investors should monitor committee assignments and any companion bill in the Senate.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Unconfirmed

No confirming evidence found yet from contracts, insider trades, or congressional activity

$$CI▼ Bearish
Est. $30.0M$70.0M revenue impact

What the bill does

Same regulatory requirements apply to Cigna's health insurance operations (Cigna Healthcare).

Who must act

Cigna's group health plans and individual coverage issuers.

What happens

Compliance costs and reduced AI-driven claims efficiency; potential increase in claims payment expenses.

Stock impact

Cigna's U.S. commercial and individual health plans rely on AI for claims processing; compliance costs in tens of millions, with margin pressure (FY2025 margin not provided, but historically ~6-7%).

$$HUM▼ Bearish
Est. $20.0M$50.0M revenue impact

What the bill does

Same regulatory requirements apply to Humana's Medicare Advantage and group health plans.

Who must act

Humana's health insurance operations.

What happens

Increased compliance burden; AI claims review restrictions may affect Medicare Advantage risk adjustment and claims management.

Stock impact

Humana's heavy reliance on Medicare Advantage (majority of revenue) means AI claims tools are critical for managing medical costs; compliance costs and reduced automation could increase administrative expenses and medical cost ratio.

Key Legislators

Rep. Landsman, Greg [D-OH-1]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderAug 26, 2026

Declaring a National Emergency to Secure the United States Bulk-Power System

This executive order declares a national emergency to restrict foreign-produced bulk-power system electric equipment that poses national security risks, prohibiting new transactions involving equipment from covered foreign entities and allowing the Secretary of Energy to impose conditions on existing equipment. It directs the Secretary of Energy, in coordination with multiple agencies, to identify, mitigate, and potentially replace risky equipment, and establishes a pre-qualification list for approved vendors.

presidential_memorandumAug 20, 2026

The National Space Transportation Policy

This memorandum directs multiple agencies to expand and modernize U.S. space launch and reentry infrastructure to support over 1,000 launches annually by 2030, expedite permitting and environmental reviews, develop new federal reentry sites, and strengthen the space transportation industrial base. It mandates range scheduling transparency, spectrum reliability, and workforce development, with specific reports and plans due within 90 to 240 days.

proclamationAug 13, 2026

Adjusting Imports of Unmanned Aircraft Systems and Unmanned Aircraft Systems Components into the United States

This proclamation imposes a 100% ad valorem tariff on imports of unmanned aircraft systems (UAS) over 25 kg, those with thermal imagers, docking stations, and certain components, and a 25% tariff on UAS under 25 kg and other components, citing national security under Section 232 of the Trade Expansion Act. It also authorizes the Department of Commerce to establish an onshoring program offering preferential tariff treatment for companies that build new U.S. manufacturing facilities for UAS and components.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →